Clinical Trials Browser

Active not recruiting × OTHER × Melanoma, Cutaneous Malignant × Clear all

NCT04620603 2026-05-05

Low-Dose-Rate Brachytherapy Combined With Immune Checkpoint Inhibition in Cancer

Phase 1 Active not recruiting

DermatologicGenitourinary

Melanoma, Cutaneous Malignant, Carcinoma, Renal Cell